A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation
Details
Age
Adult
Type of Study
Treatment
Locations
Lone Tree Medical Center
Memorial Hospital Central
Memorial Hospital North
University of Colorado Hospital
Principal Investigator
Erin Schenk, MD, PhD
Study ID
Protocol Number: 18-2529
More information available at ClinicalTrials.gov: NCT03785249
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers